HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.

AbstractINTRODUCTION:
Women with triple-negative breast cancer have the worst prognosis, frequently present with metastatic tumors and have few targeted therapy options. Notch-1 and Notch-4 are potent breast oncogenes that are overexpressed in triple-negative and other subtypes of breast cancer. PEA3, an ETS transcription factor, is also overexpressed in triple-negative and other breast cancer subtypes. We investigated whether PEA3 could be the critical transcriptional activator of Notch receptors in MDA-MB-231 and other breast cancer cells.
METHODS:
Real-time PCR and Western blot analysis were performed to detect Notch-1, Notch-2, Notch-3 and Notch-4 receptor expression in breast cancer cells when PEA3 was knocked down by siRNA. Chromatin immunoprecipitation was performed to identify promoter regions for Notch genes that recruited PEA3. TAM-67 and c-Jun siRNA were used to identify that c-Jun was necessary for PEA3 enrichment on the Notch-4 promoter. A Notch-4 luciferase reporter was used to confirm that endogenous PEA3 or AP-1 activated the Notch-4 promoter region. Cell cycle analysis, trypan blue exclusion, annexin V flow cytometry, colony formation assay and an in vivo xenograft study were performed to determine the biological significance of targeting PEA3 via siRNA, Notch signaling via a γ-secretase inhibitor, or both.
RESULTS:
Herein we provide new evidence for transcriptional regulation of Notch by PEA3 in breast cancer. PEA3 activates Notch-1 transcription in MCF-7, MDA-MB-231 and SKBr3 breast cancer cells. PEA3 activates Notch-4 transcription in MDA-MB-231 cells where PEA3 levels are endogenously high. In SKBr3 and BT474 breast cancer cells where PEA3 levels are low, overexpression of PEA3 increases Notch-4 transcripts. Chromatin immunoprecipitation confirmed the enrichment of PEA3 on Notch-1 and Notch-4 promoters in MDA-MB-231 cells. PEA3 recruitment to Notch-1 was AP-1-independent, whereas PEA3 recruitment to Notch-4 was c-JUN-dependent. Importantly, the combined inhibition of Notch signaling via a γ-secretase inhibitor (MRK-003 GSI) and knockdown of PEA3 arrested growth in the G1 phase, decreased both anchorage-dependent and anchorage-independent growth and significantly increased apoptotic cells in vitro. Moreover, either PEA3 knockdown or MRK-003 GSI treatment significantly reduced tumor growth of MDA-MB-231 xenografts in vivo.
CONCLUSIONS:
Taken together, the results from this study demonstrate for the first time that Notch-1 and Notch-4 are novel transcriptional targets of PEA3 in breast cancer cells. Targeting of PEA3 and/or Notch pathways might provide a new therapeutic strategy for triple-negative and possibly other breast cancer subtypes.
AuthorsAnthony G Clementz, Allison Rogowski, Kinnari Pandya, Lucio Miele, Clodia Osipo
JournalBreast cancer research : BCR (Breast Cancer Res) Vol. 13 Issue 3 Pg. R63 (Jun 14 2011) ISSN: 1465-542X [Electronic] England
PMID21679465 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • NOTCH1 protein, human
  • NOTCH2 protein, human
  • NOTCH3 protein, human
  • NOTCH4 protein, human
  • Peptide Fragments
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-jun
  • RNA, Small Interfering
  • Receptor, Notch1
  • Receptor, Notch2
  • Receptor, Notch3
  • Receptor, Notch4
  • Receptors, Notch
  • TAM67 peptide
  • Transcription Factor AP-1
  • Transcription Factors
  • transcription factor PEA3
  • JNK Mitogen-Activated Protein Kinases
  • Amyloid Precursor Protein Secretases
Topics
  • Amyloid Precursor Protein Secretases (antagonists & inhibitors)
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Cell Cycle
  • Cell Line, Tumor
  • Cell Proliferation
  • Chromatin Immunoprecipitation
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Peptide Fragments (genetics)
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins (genetics, metabolism)
  • Proto-Oncogene Proteins c-jun (genetics)
  • RNA Interference
  • RNA, Small Interfering
  • Receptor, Notch1 (genetics, metabolism)
  • Receptor, Notch2 (genetics, metabolism)
  • Receptor, Notch3
  • Receptor, Notch4
  • Receptors, Notch (genetics, metabolism)
  • Signal Transduction
  • Transcription Factor AP-1 (genetics, metabolism)
  • Transcription Factors (genetics, metabolism)
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: